The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Symposium

Symposium 10 Impact of innovative treatments on hematopoietic stem cell transplantations

Sun. Oct 14, 2018 1:50 PM - 4:00 PM No.1 (Osaka International Convention Center, 5F Main Hall)

Chairs: Yoshinobu Kanda (Jichi Medical University, Japan), Takahiro Fukuda (National Cancer Center Hospital, Japan)

【Ｅ】

[SY10-1] Ruxolitinib treatment for GvHD in patients with myelofibrosis

Yasuo Mori (Department of Medicine and Biosystemic Science, Kyusyu University, Fukuoka, Japan)

Professional Experience and Education
2001 M.D., Kyushu University School of Medicine
2001-2002 Internship, Kyushu University Hospital, Fukuoka, Japan
2002-2003 Internship, National Kyushu Medical Center, Fukuoka, Japan
2003-2004 Residency, Kameda Medical Center, Chiba, Japan
2004-2008 PhD student, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
2009 Ph.D., Kyushu University Graduate School of Medical Sciences
2008-2010 Medical Staff/Assistant Professor, Department of Hematology/Oncology, Kyusyu University Hospital, Fukuoka, Japan
2010-2012 Research Fellowship for Young Scientists, JSPS
2011-2014 Postdoctoral Fellow, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA
2014-Present Assistant Professor, Department of Hematology/Oncology, Kyusyu University Hospital, Fukuoka, Japan
Honors and Awards
2011 Dr. Gerald Gleich Prize, International Eosinophil Society, Inc., 7th Biennial Symposium
2015 Incentive Award, Japanese Society of Hematology

Abstract password authentication.
Password is written on a program and abstract book.

Password